Winton Group’s Wave Life Sciences WVE Stock Holding History

Winton Group’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75.3K	Sell	12,955 -52,090	-80%	-$345K	﹤0.01%	1106
2026 Q1	$472K	Buy	65,045 +50,345	+342%	+$656K	0.02%	729
2025 Q4	$250K	Buy	+14,700	New	+$149K	0.01%	781
2019 Q4	–	Sell	-25,765	Closed	-$529K	–	1786
2019 Q3	$529K	Buy	+25,765	New	+$591K	0.01%	1068

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Winton Group's WVE Position: Q2 2026 in Review

Winton Group reduced its Wave Life Sciences (WVE) stake by 80% in Q2 2026, selling an estimated $345K and leaving 12,955 shares worth $75.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

Winton Group first reported a position in WVE in Q3 2019 and has held it in 4 quarters since. The position peaked at $529K in Q3 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Winton Group held 12,955 shares of Wave Life Sciences worth $75.3K as of Q2 2026.
Winton Group sold 52,090 Wave Life Sciences shares in Q2 2026, an estimated $345K.
Wave Life Sciences made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1106 holding.
Winton Group first reported a position in Wave Life Sciences in Q3 2019 and has held it in 4 quarters since.
Winton Group's Wave Life Sciences position peaked at $529K in Q3 2019.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.